Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD)

Progress in Retinal and Eye Research

Volumn 29, Issue 3, 2010, Pages 169-190

  Ramkumar, Hema L ^a,b,c   Zhang, Jun ^a   Chan, Chi Chao ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Age related macular degeneration; AMD; Dry; Mouse model; Pathology; Retina; Ultrastructure

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN B100; APOLIPOPROTEIN E4; CARBOXYETHYLPYRROLE; CERULOPLASMIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; COPPER ZINC SUPEROXIDE DISMUTASE; FRIZZLED PROTEIN; LIPOFUSCIN; MANGANESE SUPEROXIDE DISMUTASE; MEMBRANE METALLOENDOPEPTIDASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRROLE DERIVATIVE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANATOMICAL VARIATION; BRUCH MEMBRANE; CELL ULTRASTRUCTURE; CHOLESTEROL DIET; DISEASE ACTIVITY; DRUSEN; GENE FUNCTION; GENE MUTATION; GENETIC ENGINEERING; GENETIC MANIPULATION; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; INFLAMMATION; LIPID DIET; MELANOSOME; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOLOGICAL ANATOMY; PHOTORECEPTOR CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA CELL; RETINA DYSTROPHY; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SENESCENCE ACCELERATED MOUSE; STARGARDT DISEASE; TRANSGENIC MOUSE;

AGING; ANIMALS; DISEASE MODELS, ANIMAL; GEOGRAPHIC ATROPHY; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; RETINA;

EID: 77951254301     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2010.02.002     Document Type: Review

References (231)

1. Akhmedov N.B., Piriev N.I., Chang B., Rapoport A.L., Hawes N.L., Nishina P.M., Nusinowitz S., Heckenlively J.R., Roderick T.H., Kozak C.A., Danciger M., Davisson M.T., Farber D.B. A deletion in a photoreceptor-specific nuclear receptor mRNA causes retinal degeneration in the rd7 mouse. Proc. Natl. Acad. Sci. USA 2000, 97:5551-5556.
2. Aligianis I.A., Forshew T., Johnson S. Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J. Med. Genet. 2002, 39:656-660.
3. Allikmets R., Singh N., Sun H., Shroyer N.F., Hutchinson A., Chidambaram A., Gerrard B., Baird L., Stauffer D., Peiffer A. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat. Genet. 1997, 15:236-246.
4. Alsenz J., Schulz T.F., Lambris J.D., Sim R.B., Dierich M.P. Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. Biochem. J. 1985, 232:841-850.
5. Ambasudhan R., Wang X., Jablonski M.M., Thompson D.A., Lagali P.S., Wong P.W., Sieving P.A., Ayyagari R. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Genomics 2004, 83:615-625.
6. Ambati J., Anand A., Fernandez S., Sakurai E., Lynn B.C., Kuziel W.A., Rollins B.J., Ambati B.K. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat. Med. 2003, 9:1390-1397.
7. Anderson D.H., Mullins R.F., Hageman G.S., Johnson L.V. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 2002, 134:411-431.
8. Anderson D.H., Talaga K.C., Rivest A.J., Barron E., Hageman G.S., Johnson L.V. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp. Eye Res. 2004, 78:243-256.
9. Anderson R.E. Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. Exp. Eye Res. 1970, 10:339-344.
10. Baird P.N., Guida E., Chu D.T., Vu H.T., Guymer R.H. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2004, 45:1311-1315.
11. Behndig A., Svensson B., Marklund S.L., Karlsson K. Superoxide dismutase isoenzymes in the human eye. Invest. Ophthalmol. Vis. Sci. 1998, 39:471-475.
12. Bjelik A., Bereczki E., Gonda S., Juhasz A., Rimanoczy A., Zana M., Csont T. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis. Neurochem. Int. 2006, 49:393-400.
13. Boekhoorn S.S., Vingerling J.R., Witteman J.C., Hofman A., De Jong P.T. C-reactive protein level and risk of aging macula disorder: the Rotterdam study. Arch. Ophthalmol. 2007, 125:1396-1401.
14. Bojanowski C.M., Shen D., Chew E.Y., Ning B., Csaky K.G., Green W.R., Chan C.C., Tuo J. An apolipoprotein E variant may protect against age-related macular degeneration through cytokine regulation. Environ. Mol. Mutagen. 2006, 47:594-602.
15. Bruban J., Glotin A.L., Dinet V., Chalour N., Sennlaub F., Jonet L., An N., Faussat A.M., Mascarelli F. Amyloid-beta(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell. 2009, 8:162-177.
16. Carter-Dawson L.D., LaVail M.M. Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy. J. Comp. Neurol. 1979, 188:245-262.
17. Chader G.J. Animal models in research on retinal degenerations: past progress and future hope. Vision Res. 2002, 42:393-399.
18. Chan C.C., Tuo J., Bojanowski C.M., Csaky K.G., Green W.R. Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. Histol. Histopathol. 2005, 20:857-863.
19. Chan C.C., Ross R.J., Shen D., Ding X., Majumdar Z., Bojanowski C.M., Zhou M., Salem N., Bonner R., Tuo J. Ccl2/Cx3cr1-deficient mice: an animal model for age-related macular degeneration. Ophthalmic Res. 2008, 40:124-128.
20. Chang B., Heckenlively J.R., Hawes N.L., Davisson M.T. A new mouse model of retinal dysplasia and degeneration (rd7). Invest. Ophthalmol. Vis. Sci. 1998, 39(Suppl.).
21. Chang B., Hawes N.L., Hurd R.E., Davisson M.T., Nusinowitz S., Heckenlively J.R. Retinal degeneration mutants in the mouse. Vision Res. 2002, 42:517-525.
22. Chang B., Hawes N.L., Hurd R.E., Wang J., Howell D., Davisson M.T., Roderick T.H., Nusinowitz S., Heckenlively J.R. Mouse models of ocular diseases. Vis. Neurosci. 2005, 22:587-593.
23. Chang B., Dacey M.S., Hawes N.L., Hitchcock P.F., Milam A.H., Atmaca-Sonmez P., Nusinowitz S., Heckenlively J.R. Cone photoreceptor function loss-3, a novel mouse model of achromotopsia due to a mutation in Gnat2. Invest. Ophthalmol. Vis. Sci. 2006, 47:5017-5021.
24. Chang B., Mandal M.N., Chavali V.R., Hawes N.L., Khan N.W., Hurd R.E., Smith R.S., Davisson M.L., Kopplin L., Klein B.E., Klein R., Iyengar S.K., Heckenlively J.R., Ayyagari R. Age-related retinal degeneration (arrd2) in a novel mouse model due to a nonsense mutation in the Mdm1 gene. Hum. Mol. Genet. 2008, 17:3929-3941.
25. Chen L., Dentchev T., Wong R., Hahn P., Wen R., Bennett J., Dunaief J.L. Increased expression of ceruloplasmin in the retina following photic injury. Mol. Vis. 2003, 9:151-158.
26. Chen H., Attieh Z.K., Su T., Syed B.A., Gao H., Alaeddine R.M., Fox T.C., Usta J., Naylor C.E., Evans R.W., Mckie A.T., Anderson G.J., Vulpe C.D. Hephaestin is a ferroxidase that maintains partial activity in sex-linked anemia mice. Blood 2004, 103:3933-3939.
27. Cheng H., Khanna H., Oh E.C., Hicks D., Mitton K.P., Swaroop A. Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors. Hum. Mol. Genet. 2004, 13:1563-1575.
28. Cherepanoff S., Mitchell P., Wang J.J., Gillies M.C. Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clin. Exp. Ophthalmol. 2006, 34:590-595.
29. Chong N.H.V., Alexander R.A., Gin T., Bird A.C., Luthert P.J. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest. Ophthalmol. Vis. Sci. 2000, 41:898-902.
30. Coffey P.J., Gias C., Mcdermott C.J., Lundh P., Pickering M.C., Sethi C., Bird A., Fitzke F.W., Maass A., Chen L.L., Holder G.E., Luthert P.J., Salt T.E., Moss S.E., Greenwood J. Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc. Natl. Acad. Sci. USA 2007, 104:16,651-16,656.
31. Coleman H.R., Chan C.C., Ferris F.L., Chew E.Y. Age-related macular degeneration. Lancet 2008, 372:1835-1845.
32. Collins T. A pathological report upon a case of Doyne's choroiditis ('honeycomb' or 'family choroidits'). Ophthalmoscope 1913, 11:537-538.
33. Combadiere C., Feumi C., Raoul W., Keller N., Rodero M., Pezard A., Lavalette S., Houssier M., Jonet L., Picard E., Debre P., Sirinyan M., Deterre P., Ferroukhi T., Cohen S.Y., Chauvaud D., Jeanny J.C., Chemtob S., Behar-Cohen F., Sennlaub F. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest. 2007, 117:2920-2928.
34. Congdon N., O'colmain B., Klaver C.C., Klein R., Munoz B. Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 2004, 122:477-485.
35. Cousins S.W., Espinosa-Heidmann D.G., Alexandridou A., Sall J., Dubovy S., Csaky K. The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp. Eye Res. 2002, 75:543-553.
36. Cousins S.W., Marin-Castano M.E., Espinosa-Heidmann D.G., Alexandridou A., Striker L., Elliot S. Female gender, estrogen loss, and Sub-RPE deposit formation in aged mice. Invest. Ophthalmol. Vis. Sci. 2003, 44:1221-1229.
37. Crabb J.W., Miyagi M., Gu X., Shadrach K., West K.A., Sakaguchi H., Kamei M., Hasan A., Yan L., Rayborn M.E., Salomon R.G., Hollyfield J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2002, 99:14,682-14,687.
38. Cruickshanks K.J., Klein R., Klein B.E. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch. Ophthalmol. 1993, 111:514-518.
39. Curcio C.A., Millican C.L. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch. Ophthalmol. 1999, 117:329-339.
40. Curcio C.A., Medeiros N.E., Millican C.L. Photoreceptor loss in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 1996, 37:1236-1249.
41. Curcio C.A., Millican C.L., Bailey T., Kruth H.S. Accumulation of cholesterol with age in human Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 2001, 42:265-274.
42. Dastgheib K., Green W.R. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch. Ophthalmol. 1994, 112:813-818.
43. Dentchev T., Milam A.H., Lee V.M., Trojanowski J.Q., Dunaief J.L. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol. Vis. 2003, 9:184-190.
44. Ding X., Patel M., Chan C.C. Molecular pathology of age-related macular degeneration. Prog. Retinal Eye Res. 2009, 28:1-18.
45. Dithmar S., Curcio C.A., Le N.A., Brown S., Grossniklaus H.E. Ultrastructural changes in Bruch's membrane of apolipoprotein E-deficient mice. Invest. Ophthalmol. Vis. Sci. 2000, 41:2035-2042.
46. Dithmar S., Sharara N.A., Curcio C.A., Le N.A., Zhang Y., Brown S., Grossniklaus H.E. Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch. Ophthalmol. 2001, 119:1643-1649.
47. Doly M., Bonhomme B., Vennat J.C. Experimental study of the retinal toxicity of hemoglobinic iron. Ophthalmic Res. 1986, 18:21-27.
48. Ebrahem Q., Renganathan K., Sears J., Vasanji A., Gu X., Lu L., Salomon R.G., Crabb J.W., Anand-Apte B. Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: implications for age-related macular degeneration. Proc Natl. Acad. Sci. USA 2006, 103:13,480-13,484.
49. Edwards A.O., Ritter R., Abel K.J., Manning A., Panhuysen C., Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
50. Enzinger C., Ropele S., Smith S., Strasser-Fuchs S., Poltrum B., Schmidt H., Matthews P.M., Fazekas F. Accelerated evolution of brain atrophy and " black holes" in MS patients with APOE-epsilon 4. Ann. Neurol. 2004, 55:563-569.
51. Espinosa-Heidmann D.G., Sall J., Hernandez E.P., Cousins S.W. Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest. Ophthalmol. Vis. Sci. 2004, 45:260-266.
52. Espinosa-Heidmann D.G., Suner I.J., Catanuto P., Hernandez E.P., Marin-Castano M.E., Cousins S.W. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest. Ophthalmol. Vis. Sci. 2006, 47:729-737.
53. Ethen C.M., Reilly C., Feng X., Olsen T.W., Ferrington D.A. The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:2280-2290.
54. Farkas T.G., Sylvester V., Archer D., Altona M. The histochemistry of drusen. Am. J. Ophthalmol. 1971, 71:1206-1215.
55. Feeney-Burns L., Eldred G.E. The fate of the phagosome: conversion to " age pigment" and impact in human retinal pigment epithelium. Trans. Ophthalmol. Soc. U.K. 1983, 103:416-421.
56. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247.
57. Fisher S.A., Abecasis G.R., Yashar B.M., Zareparsi S., Swaroop A., Iyengar S.K., Klein B.E., Klein R., Lee K.E., Majewski J., Schultz D.W., Klein M.L., Seddon J.M., Santangelo S.L., Weeks D.E., Conley Y.P., Mah T.S., Schmidt S., Haines J.L., Pericak-Vance M.A., Gorin M.B., Schulz H.L., Pardi F., Lewis C.M., Weber B.H. Meta-analysis of genome scans of age-related macular degeneration. Hum. Mol. Genet. 2005, 14:2257-2264.
58. Fogarasi M., Janssen A., Weber B.H., Stohr H. Molecular dissection of TIMP3 mutation S156C associated with Sorsby fundus dystrophy. Matrix Biol. 2008, 27:381-392.
59. Francis P.J., Zhang H., Dewan A., Hoh J., Klein M.L. Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and CFH genes on AMD in a Caucasian population. Mol. Vis. 2008, 14:1395-1400.
60. Friedman D.S., Bj O'colmain, Muñoz B., Sc Tomany, Mccarty C., Jong Pt De, Nemesure B., Mitchell P., Kempen J. Prevalence of age-related macular degeneration in the United States. Arch. Ophthalmol. 2004, 122:564-572. The Eye Diseases Prevalence Research Group.
61. Fu L., Garland D., Yang Z., Shukla D., Rajendran A., Pearson E., Stone E.M., Zhang K., Pierce E.A. The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum. Mol. Genet. 2007, 16:2411-2422.
62. Fujihara M., Bartels E., Nielsen L.B., Handa J.T. A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp. Eye Res. 2009, 88:1115-1123.
63. Fuller P. The steroid receptor superfamily: mechanism of diversity. FASEB J. 1991, 5:3092-3099.
64. Gao H., Hollyfield J.G. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 1992, 33:1-17.
65. Gehrs K.M., Anderson D.H., Johnson L.V., Hageman G.S. Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann. Med. 2006, 38:450-471.
66. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006, 38:458-462.
67. Gosbell A.D., Stefanovic N., Scurr L.L., Pete J., Kola I., Favilla I., De Haan J.B. Retinal light damage: structural and functional effects of the antioxidant glutathione peroxidase-1. Invest. Ophthalmol. Vis. Sci. 2006, 47:2613-2622.
68. Green W.R., Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman lecture. Ophthalmology 1993, 100:1519-1535.
69. Green W.R. Histopathology of age-related macular degeneration. Mol. Vis 1999, 5.
70. Gu X., Meer S.G., Miyagi M., Rayborn M.E., Hollyfield J.G., Crabb J.W., Salomon R.G. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J. Biol. Chem. 2003, 278:42,027-42,035.
71. Hadziahmetovic M., Dentchev T., Song Y., Haddad N., He X., Hahn P., Pratico D., Wen R., Harris Z.L., Lambris J.D., Beard J., Dunaief J.L. Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest. Ophthalmol. Vis. Sci. 2008, 49:2728-2736.
72. Hafezi F., Grimm C., Simmen B.C., Wenzel A., Remé C.E. Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies. Br. J. Ophthalmol. 2000, 84:922-927.
73. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., Smith R.J., Silvestri G., Russell S.R., Klaver C.C., Barbazetto I., Chang S., Yannuzzi L.A., Barile G.R., Merriam J.C., Smith R.T., Olsh A.K., Bergeron J., Zernant J., Merriam J.E., Gold B., Dean M., Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2005, 102:7227-7232.
74. Hahn P., Milam A.H., Dunaief J.L. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Arch. Ophthalmol. 2003, 121:1099-1105.
75. Hahn P., Qian Y., Dentchev T., Chen L., Beard J., Harris Z.L., Dunaief J.L. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2004, 101:13,850-13,855.
76. Haider N.B., Jacobson S.G., Cideciyan A.V., Swiderski R., Streb L.M., Searby C., Beck G., Hockey R., Hanna D.B., Gorman S. Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat. Genet. 2000, 24:127-131.
77. Haider N.B., Naggert J.K., Nishina P.M. Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice. Hum. Mol. Genet. 2001, 10:1619-1626.
78. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., Schnetz-Boutaud N., Agarwal A., Postel E.A., Pericak-Vance M.A. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
79. Haley P.J. Species differences in the structure and function of the immune system. Toxicology 2003, 188:49-71.
80. Hawes N.L., Smith R.S., Chang B., Davisson M.L., Heckenlively J.R., John S.W. Mouse fundus photography and angiography: a catalogue of normal and mutant phenotypes. Mol. Vis. 1999, 15.
81. Hawes N.L., Chang B., Hageman G.S., Nusinowitz S., Nishina P.M., Schneider B.S., Smith R.S., Roderick T.H., Davisson M.T., Heckenlively J.R. Retinal degeneration 6 (rd6): a new mouse model for human retinitis punctata albescens. ARVO 2000, 41:3149-3157.
82. Hayasaka S. Lysosomal enzymes in ocular tissues and diseases. Surv. Ophthalmol. 1983, 27:245-258.
83. He X., Hahn P., Iacovelli J., Wong R., King C., Bhisitkul R., Massaro-Giordano M., Dunaief J.L. Iron homeostasis and toxicity in retinal degeneration. Prog. Retin Eye Res. 2007, 26:649-673.
84. Heckenlively J.R., Chang B., Erway L.C., Peng C., Hawes N.L., Hageman G.S., Roderick T.H. Mouse model for Usher syndrome: linkage mapping suggests homology to Usher type I reported at human chromosome 11p15. Proc. Natl. Acad. Sci. USA 1995, 92:11,100-11,104.
85. Herzlich A.A., Tuo J., Chan C.C. Peroxisome proliferator-activated receptor and age-related macular degeneration. PPAR Res. 2008, 2008:389,507.
86. Hogan M.J., Alvarado J. Studies on the human macula: IV. Aging changes in Bruch's membrane. Arch. Ophthalmol. 1967, 77:410-420.
87. Hogg R.E., Chakravarthy U. Visual function and dysfunction in early and late age related maculopathy. Prog. Retin Eye Res. 2006, 25:249-276.
88. Hollyfield J.G., Bonilha V.L., Rayborn M.E., Yang X., Shadrach K.G., Lu L., Ufret R.L., Salomon R.G., Perez V.L. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med 2008, 14:194-198.
89. Hutchinson J., Tay W. Symmetrical central chorioretinal disease occurring in senile persons. R. London Ophthalmol. Hosp. Rep. 1875, 8:231-244.
90. Imamura Y., Noda S., Hashizume K., Shinoda K., Yamaguchi M., Uchiyama S., Shimizu T., Mizushima Y., Shirasawa T., Tsubota K. Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2006, 103:11,282-11,287.
91. Iwata N., Tsubuki S., Takaki Y., Shirotani K., Lu B., Gerard N.P., Gerard C., Hama E., Lee H.J., Saido T.C. Metabolic regulation of brain Abeta by neprilysin. Science 2001, 292:1550-1552.
92. Iwata N., Takaki Y., Fukami S., Tsubuki S., Saido T.C. Region-specific reduction of A beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 2002, 70:493-500.
93. Iyengar S.K., Song D., Klein B.E., Klein R., Schick J.H., Humphrey J., Millard C., Liptak R., Russo K., Jun G., Lee K.E., Fijal B., Elston R.C. Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am. J. Hum. Genet. 2004, 74:20-39.
94. Javitt N.B., Javitt J.C. The retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degeneration. Curr. Opin. Ophthalmol. 2009, 20:151-157.
95. Jeon C.J., Strettoi E., Masland R.H. The major cell populations of the mouse retina. J. Neurosci. 1998, 18:8936-8946.
96. Joachim S.C., Bruns K., Lackner K.J., Pfeiffer N., Grus F.H. Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with " wet" age-related macular degeneration. Graefes Arch. Clin. Exp. Ophthalmol. 2007, 245:619-626.
97. Johnson L.V., Leitner W.P., Rivest A.J., Staples M.K., Radeke M.J., Anderson D.H. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2002, 99:11,830-11,835.
98. Johnson P.T., Betts K.E., Radeke M.J., Hageman G.S., Anderson D.H., Johnson L.V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. USA 2006, 103:17,456-17,461.
99. Jones S.E., Jomary C., Grist J., Stewart H.J., Neal M.J. Modulated expression of secreted frizzled-related proteins in human retinal degeneration. Neuroreport 2000, 11:3963-3967.
100. Justilien V., Pang J.J., Renganathan K., Zhan X., Crabb J.W., Kim S.R., Sparrow J.R., Hauswirth W.W., Lewin A.S. SOD2 knockdown mouse model of early AMD. Invest. Ophthalmol. Vis. Sci. 2007, 48:4407-4420.
101. Kalaria R.N. Arteriosclerosis, apolipoprotein E, and Alzheimer's disease. Lancet 1997, 349:1174.
102. Kameya S., Hawes N.L., Chang B., Heckenlively J.R., Naggert J.K., Nishina P.M. Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6. Hum. Mol. Genet. 2002, 11:1879-1886.
103. Karan G., Lillo C., Yang Z., Cameron D.J., Locke K.G., Zhao Y., Thirumalaichary S., Li C., Birch D.G., Vollmer-Snarr H.R., Williams D.S., Zhang K. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc. Natl. Acad. Sci. USA 2005, 102:4164-4169.
104. Katz M.L., Robison W.G. Evidence of cell loss from the rat retina during senescence. Exp. Eye Res. 1986, 42:293-304.
105. Kawamata T., Akiguchi I., Yagi H. Neuropathological studies on strains of senescense-accelerated mice (SAM) with age related deficits in learning and memory. Exp. Gerontol. 1997, 1997:161-169.
106. Keeler C.E. The inheritance of a retinal abnormality in white mice. Proc. Natl. Acad. Sci. 1924, 10:329-333.
107. Kim S.Y., Sadda S., Humayun M.S., De Juan E., Melia B.M., Green W.R. Morphometric analysis of the macula in eyes with geographic atrophy due to age-related macular degeneration. Retina 2002, 22:464-470.
108. Kitado H., Higuchi K., Takeda T. Molecular genetic characterization of the senescence-accelerated mouse (SAM) strains. J. Gerontol. 1994, 49:B247-B254.
109. Klaver C.C., Kliffen M., Van Duijn C.M., Hofman A., Cruts M., Grobbee D.E., Van Broeckhoven C., De Jong P.T. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J Hum. Genet. 1998, 63:200-206.
110. Klein M.L., Schultz D.W., Edwards A., Matise T.C., Rust K., Berselli C.B., Trzupek K., Weleber R.G., Ott J., Wirtz M.K., Acott T.S. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch. Ophthalmol. 1998, 116:1082-1088.
111. Klein R., Clegg L., Cooper L.S., Hubbard L.D., Klein B.E., King W.N., Folsom A.R. Prevalence of age-related maculopathy in the atherosclerosis risk in communities study. Arch. Ophthalmol. 1999, 117:1203-1210.
112. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., Sangiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
113. Klein R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthal. Epidemiol. 2007, 14:184-187.
114. Kliffen M., Lutgens E., Daemen M.J., De Muinck E.D., Mooy C.M., De Jong P.T. The APOE3-Leiden mouse as an animal model for basal laminar deposit. Br J Ophthalmol 2000, 84:1415-1419.
115. Klomp L.W., Gitlin J.D. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 1996, 5:1989-1996.
116. Klomp L.W., Farhangrazi Z.S., Dugan L.L., Gitlin J.D. Ceruloplasmin gene expression in the murine central nervous system. J. Clin. Invest. 1996, 98:207-215.
117. Kuziel W.A., Morgan S.J., Dawson T.C., Griffin S., Smithies O., Ley K., Maeda N. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc. Natl. Acad. Sci. USA 1997, 94:12,053-12,058.
118. Leys A., Vanrenterghem Y., Van Damme B., Snyers B., Pirson Y., Leys M. Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch. Clin. Exp. Ophthalmol. 1991, 229:406-410.
119. Li Y., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson J.L., Noble L.J., Yoshimura M.P., Berger C., Chan P.H., Wallace D.C., Epstein C.J. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 1995, 11:376-381.
120. Li D., Sun F., Wang K. Protein profile of aging and its retardation by caloric restriction in neural retina. Biochem. Biophys. Res. Commun. 2004, 318:253-258.
121. Lu B., Rutledge B.J., Gu L., Fiorillo J., Lukacs N.W., Kunkel S.L., North R., Gerard C., Rollins B.J. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J. Exp. Med. 1998, 187:601-608.
122. Lu B., Malcuit C., Wang S., Girman S., Francis P., Lemieux L., Lanza R., Lund R. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009, 27:2126-2135.
123. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988, 240:622-630.
124. Majji A.B., Cao J., Chang K.Y., Hayashi A., Aggarwal S., Grebe R.R., De Juan E.J. Age-related retinal pigment epithelium and Bruch's membrane degeneration in senescence-accelerated mouse. Invest. Ophthalmol. Vis. Sci. 2000, 41:3936-3942.
125. Malek G., Johnson L.V., Mace B.E., Saloupis P., Schmechel D.E., Rickman D.W., Toth C.A., Sullivan P.M., Bowes Rickman C. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc. Natl. Acad. Sci. USA 2005, 102:11,900-11,905.
126. Maller J., George S., Purcell S., Fagerness J., Altshuler D., Daly M.J., Seddon J.M. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat. Genet. 2006, 38:1055-1059.
127. Marmorstein A.D., Marmorstein L.Y. The challenge of modeling macular degeneration in mice. TRENDS Genet. 2007, 23:225-231.
128. Marmorstein L.Y., Mclaughlin P.J., Peachey N.S., Sasaki T., Marmorstein A.D. Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum. Mol. Genet. 2007, 16:2423-2432.
129. Martin D.F., Debarge L.R., Nussenblatt R.B., Chan C.C., Roberge F.G. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis. J. Immunol. 1995, 154:922-927.
130. Mata N.L., Tzekov R.T., Liu X., Weng J., Birch D.G., Travis G. Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2001, 42:1685-1690.
131. Matrisian L.M. The matrix-degrading metalloproteinases. Bioessays 1992, 14:455-463.
132. Mcgeer E.G., Klegeris A., Mcgeer P.L. Inflammation, the complement system and the diseases of aging. Neurobiol. Aging 2005, 26(Suppl. 1):94-97.
133. Mclaughlin P.J., Bakall B., Choi J., Liu Z., Sasaki T., Davis E.C., Marmorstein A.D., Marmorstein L.Y. Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Hum. Molec. Genet. 2007, 16:3059-3070.
134. Melov S., Schneider J.A., Day B.J., Hinerfeld D., Coskun P., Mirra S.S., Crapo J.D., Wallace D.C. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 1998, 18:159-163.
135. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J. Immunol. 2004, 172:2731-2738.
136. Miceli M.V., Newsome D.A., Tate D.J., Sarphie T.G. Pathologic changes in the retinal pigment epithelium and Bruch's membrane of fat-fed atherogenic mice. Curr. Eye Res. 2000, 20:8-16.
137. Mishima H., Hasebe H. Some observations in the fine structure of age changes of the mouse retinal pigment epithelium. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 1978, 209:1-9.
138. Mishima H., Kondo K. Extrusion of lysosomal bodies from apical mouse retinal pigment epithelium. Albrecht Von Graefes Arch. Klin. Exp Ophthalmol 1981, 216:209-217.
139. Moore D.J., Hussain A.A., Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest. Ophthalmol. Vis. Sci. 1995, 36:1290-1297.
140. Mullins R.F., Russell S.R., Anderson D.H., Hageman G.S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000, 14:835-846.
141. Neuner B., Komm A., Wellmann J., Dietzel M., Pauleikhoff D., Walter J., Busch M., Hense H.W. Smoking history and the incidence of age-related macular degeneration-Results from the Muenster Aging and Retina Study (MARS) cohort and systematic review and meta-analysis of observational longitudinal studies. Addict Behav. 2009, 34:938-947.
142. Nussenblatt R.B., Salinas-Carmona M., Waksman B.H., Gery I. Cyclosporin A: alterations of the cellular immune response in S-antigen-induced experimental autoimmune uveitis. Int. Arch. Allergy Appl. Immunol. 1983, 70:289-294.
143. Nussenblatt R.B. Bench to bedside: new approaches to the immunotherapy of uveitic disease. Int. Rev. Immunol. 2002, 21:273-289.
144. Ogata N., Ohkuma H., Kanai K., Nango K., Takada Y., Uyama M. Histological changes in the retinal pigment epithelium and Bruch's membrane in senescence accelerated mouse. Nippon Ganka Gakkai Zasshi 1992, 96:180-189.
145. Panda-Jonas S., Jonas J.B., Jakobczyk-Zmija M. Retinal photoreceptor density decreases with age. Ophthalmology 1995, 102:1853-1859.
146. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 1:893-895.
147. Patel M., Chan C.C. Immunopathological aspects of age-related macular degeneration. Semin. Immunopathol. 2008, 30:97-110.
148. Patel B.N., David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 1997, 272:20,185-20,190.
149. Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 2002, 22:6578-6586.
150. Patel N., Ohbayashi M., Nugent A.K., Ramchand K., Toda M., Chau K.Y., Bunce C., Webster A., Bird A.C., Ono S.J., Chong V. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005, 115:422-430.
151. Pauleikhoff D., Harper C.A., Marshall J., Bird A.C. Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology 1990, 97:171-178.
152. Pitas R.E., Boyles J.K., Lee S.H., Hui D., Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B, E(LDL) receptors in the brain. J. Biol. Chem. 1987, 262:14,352-14,360.
153. Purcell-Huynh D.A., Farese R.V., Johnson D.F., Flynn L.M., Pierotti V., Newland D.L., Linton M.F., Sanan D.A., Young S.G. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J. Clin. Invest. 1995, 95:2246-2257.
154. Raines M.F., Duvall-Young J., Short C.D. Fundus changes in mesangiocapillary glomerulonephritis type II: vitreous fluorophotometry. Br. J. Ophthalmol. 1989, 73:411-431.
155. Rakoczy P.E., Lai C.M., Baines M., Di Grandi S., Fitton J.H., Constable I.J. Modulation of cathepsin D activity in retinal pigment epithelial cells. Biochem J. 1997, 324(Pt 3):935-940.
156. Rakoczy P.E., Zhang D., Robertson T., Barnett N.L., Papadimitriou J., Constable I.J., Lai C.M. Progressive age-related changes similar to age-related macular degeneration in a transgenic mouse model. Am. J. Pathol. 2002, 161:1515-1524.
157. Rakoczy E.P., Meaghan J.T., YuNusinowitz S., Chang B., Heckenlively J.R. Mouse models of age-related macular degeneration. Exp. Eye Res. 2006, 82:741-752.
158. Raz-Prag D., Ayyagari R., Fariss R.N., Mandal M.N., Vasireddy V., Majchrzak S., Webber A.L., Bush R.A., Salem N., Petrukhin K., Sieving P.A. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease. Invest. Ophthalmol. Vis. Sci. 2006, 47:3603-3611.
159. Roque R.S., Rosales A.A., Jingjing L., Agarwal N., Al-Ubaidi M.R. Retina-derived microglial cells induce photoreceptor cell death in vitro. Brain Res. 1999, 836:110-119.
160. Ross R.J., Zhou M., Shen D., Fariss R.N., Ding X., Bojanowski C.M., Tuo J., Chan C.C. Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. Exp. Eye Res. 2008, 86:675-683.
161. Rudolf M., Ivandic B., Winkler J., Schmidt-Erfurth U. Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration. Ophthalmologe 2004, 101:715-719.
162. Saido T.C. Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid. Neurobiol. Aging 1998, 19:S69-S75.
163. Sallo F.B., Bereczki E., Csont T., Luthert P.J., Munro P., Ferdinandy P., Santha M., Lengyel I. Bruch's membrane changes in transgenic mice overexpressing the human biglycan and apolipoprotein b-100 genes. Exp. Eye Res. 2009, 89:178-186.
164. Sandbach J.M., Coscun P.E., Grossniklaus H.E., Kokoszka J.E., Newman N.J., Wallace D.C. Ocular pathology in mitochondrial superoxide dismutase (Sod2)-deficient mice. Invest. Ophthalmol Vis. Sci. 2001, 42:2173-2178.
165. Sanyal S., Hawkins R.K. Development and degeneration of retina in rds mutant mice: effects of light on the rate of degeneration in albino and pigmented homozygous and heterozygous mutant and normal mice. Vis. Res. 1986, 26:1177-1185.
166. Sarks S.H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 1976, 60:324-341.
167. Seddon J.M., Gensler G., Milton R.C., Klein M.L., Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004, 291:704-710.
168. Seddon J.M., Cote J., Page W.F., Aggen S.H., Neale M.C. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch. Ophthalmol. 2005, 123:321-327.
169. Shelley E.J., Madigan M.C., Natoli R., Penfold P.L., Provis J.M. Cone degeneration in aging and age-related macular degeneration. Arch. Ophthalmol. 2009, 127:483-492.
170. Shepherd F.A., Sridhar S.S. Angiogenesis inhibitors under study for the treatment of lung cancer. Lung Cancer 2003, 41(Suppl. 1):S63-S72.
171. Shoji M., Okada M., Ohta A., Higuchi K., Hosokawa M., Honda Y. A morphological and morphometrical study of the retina in aging SAM mice. Ophthal. Res. 1998, 30:172-179.
172. Sickel W. Electrical and metabolic manifestations of receptor and higherorder neuron activity in vertebrate retina. Adv. Exp. Med. Biol. 1972, 24:101-118.
173. Snow K.K., Seddon J.M. Do age-related macular degeneration and cardiovascular disease share common antecedents?. Ophthal. Epidemiol. 1999, 6:125-143.
174. Sorsby A., Mason M.E.J., Gardner N. A fundus dystrophy with unusual features. Br. J. Ophthalmol. 1949, 33.
175. Spraul C.W., Grossniklaus H.E. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch. Ophthalmol. 1997, 115:267-273.
176. Stargardt K. Uber familiare, progressive degeneration in der maculagegend des auges. Graefes Arch. Ophthalmol. 1909, 71:534-550.
177. Starita C., Hussain A.A., Pagliarini S., Marshall J. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp. Eye Res. 1996, 62:565-572.
178. Stone E.M., Nichols B.E., Kimura A.E., Weingeist T.A., Drack A., Sheffield V.C. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch. Ophthalmol. 1994, 112:765-772.
179. Stone E.M., Fingert J.H., Alward W.L.M., Nguyen T.D., Polansky J.R. Identification of a gene that causes primary open angle glaucoma. Science 1997, 275:668-670.
180. Stone E.M., Lotery A.J., Munier F.L., Heon E., Piguet B., Guymer R.H., Vandenburgh K., Cousin P., Nishimura D., Swiderski R.E. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat. Genet. 1999, 22:199-202.
181. Stone E.M., Braun T.A., Russell S.R., Kuehn M.H., Lotery A.J., Moore P.A., Eastman C.G., Casavant T.L., Sheffield V.C. Missense variations in the fibulin 5 gene and age-related macular degeneration. N. Engl. J. Med. 2004, 351:346-353.
182. Strohmeyer R., Ramirez M., Cole G.J., Mueller K., Rogers J. Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. J. Neuroimmunol. 2002, 131:135-146.
183. Sullivan P.M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R.L., Quarfordt S.H., Maeda N. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 1997, 272:17,972-17,980.
184. Swaroop A., Branham K.E., Chen W., Abecasis G. Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits. Hum. Mol. Genet. 2007, 16:R174-R182.
185. Szel A., Rohlich P., Caffe A.R., Juliusson B., Aguirre G., Van Veen T. Unique topographic separation of two spectral classes of cones in the mouse retina. J Comp. Neurol. 1992, 325:327-342.
186. Takada Y., Ogata N., Ohkuma H., Uyama M. Age-related changes in Bruch's membrane of the senescence accelerated mouse. Nippon Ganka Gakkai Zasshi 1993, 97:595-601.
187. Takada Y., Uyama M., Ohkuma H., Ogata N., Matsushima M., Deguchi J., Sugasawa K. Immunohistological study in Bruch's membrane of senescence accelerated mouse. Nippon Ganka Gakkai Zasshi 1994, 98:955-961.
188. Takeda T., Hosokawa M., Higuchi K., Hosono M., Akiguchi I., Katoh H. A novel murine model of aging, Senescence-Accelerated Mouse (SAM). Arch. Gerontol. Geriatr. 1994, 19:185-192.
189. Takeda T., Hosokawa M., Higuchi K. Senescence-accelerated mouse (SAM): a novel murine model of senescence. Exp. Gerontol. 1997, 32:105-109.
190. Timpl R., Sasaki T., Kostka G., Chu M.L. Fibulins: a versatile family of extracellular matrix proteins. Nat. Rev. Mol. Cell. Biol. 2003, 4:479-489.
191. Tree M. Familial hyaline dystrophy in the fundus oculi or Doyne's family honeycomb " choroiditis" Br. J. Ophthalmol. 1937, 21:65-91.
192. Tsutsumi C.S.K., Egashira K., Qiao H., Hisatomi T., Nakao S., Ishibashi M., Charo I.F., Sakamoto T., Murata T., Ishibashi T. The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J. Leukoc. Biol. 2003, 74:25-32.
193. Tuo J., Smith B.C., Bojanowski C.M., Meleth A.D., Gery I., Csaky K.G., Chew E.Y., Chan C.C. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J. 2004, 18:1297-1299.
194. Tuo J., Bojanowski C.M., Zhou M., Shen D., Ross R.J., Rosenberg K.I., Cameron D.J., Yin C., Kowalak J.A., Zhuang Z., Zhang K., Chan C.C. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2007, 48:3827-3836.
195. Tuo J., Ross R.J., Herzlich A.A., Shen D., Ding X., Zhou M., Coon S.L., Hussein N., Salem N., Chan C.C. A high omega-3 fatty acid diet reduces retinal lesions in a murine model of macular degeneration. Am. J. Pathol 2009, 175:799-807.
196. Uchihara T., Akiyama H., Kondo H., Ikeda K. Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain. Stroke 1997, 28:1948-1950.
197. Umeda S., Ayyagari R., Allikmets R., Suzuki M.T., Karoukis A.J., Ambasudhan R., Zernant J., Okamoto H., Ono F., Terao K., Mizota A., Yoshikawa Y., Tanaka Y., Iwata T. Early-onset macular degeneration with drusen in a cynomolgus monkey (Macaca fascicularis) pedigree: exclusion of 13 candidate genes and loci. Invest. Ophthalmol. Vis. Sci. 2005, 46:683-691.
198. Umeda S., Suzuki M.T., Okamoto H., Ono F., Mizota A., Terao K., Yoshikawa Y., Tanaka Y., Iwata T. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J. 2005, 19:1683-1685.
199. Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005, 74:563-593.
200. Van Den Maagdenberg A.M., Hofker M.H., Krimpenfort P.J., De Bruijn I., Van Vlijmen B., Van Der Boom H., Havekes L.M., Frants R.R. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 1993, 268:10,540-10,545.
201. Van Der Schaft T.L., Mooy C.M., De Bruijn W.C., Oron F.G., Mulder P.G., De Jong P.T. Histologic features of the early stages of age-related macular degeneration. A statistical analysis. Ophthalmology 1992, 99:278-286.
202. Van Nie R., Ivanyi D., Demant P. A new H-2-linked mutation, rds, causing retinal degeneration in the mouse. Tissue Antigens 1978, 12:106-108.
203. Vasireddy V., Vijayasarathy C., Huang J., Wang X.F., Jablonski M.M., Petty H.R., Sieving P.A., Ayyagari R. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes. Mol. Vis. 2005, 11:665-676.
204. Vasireddy V., Jablonski M.M., Mandal M.N.A., Raz-Prag D., Wang X.F., Nizol L., Iannaccone A., Musch D.C., Bush R.A., Salem N. Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration. ARVO 2006, 47:4558.
205. Vasireddy V., Jablonski M.M., Khan N.W., Wang X.F., Sahu P., Sparrow J.R., Ayyagari R. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin. Exp. Eye Res. 2009.
206. Vingerling J.R., Hofman A., Grobbee D.E., De Jong P.T. Age-related macular degeneration and smoking. The Rotterdam study. Arch. Ophthalmol. 1996, 114:1193-1196.
207. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., Gitschier J., Anderson G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 1999, 21:195-199.
208. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., Agarwal P., Agarwala R., Ainscough R., Alexandersson M., An P., Antonarakis S.E., Attwood J., Baertsch R., Bailey J., Barlow K., Beck S., Berry E., Birren B., Bloom T., Bork P., Botcherby M., Bray N., Brent M.R., Brown D.G., Brown S.D., Bult C., Burton J., Butler J., Campbell R.D., Carninci P., Cawley S., Chiaromonte F., Chinwalla A.T., Church D.M., Clamp M., Clee C., Collins F.S., Cook L.L., Copley R.R., Coulson A., Couronne O., Cuff J., Curwen V., Cutts T., Daly M., David R., Davies J., Delehaunty K.D., Deri J., Dermitzakis E.T., Dewey C., Dickens N.J., Diekhans M., Dodge S., Dubchak I., Dunn D.M., Eddy S.R., Elnitski L., Emes R.D., Eswara P., Eyras E., Felsenfeld A., Fewell G.A., Flicek P., Foley K., Frankel W.N., Fulton L.A., Fulton R.S., Furey T.S., Gage D., Gibbs R.A., Glusman G., Gnerre S., Goldman N., Goodstadt L., Grafham D., Graves T.A., Green E.D., Gregory S., Guigo R., Guyer M., Hardison R.C., Haussler D., Hayashizaki Y., Hillier L.W., Hinrichs A., Hlavina W., Holzer T., Hsu F., Hua A., Hubbard T., Hunt A., Jackson I., Jaffe D.B., Johnson L.S., Jones M., Jones T.A., Joy A., Kamal M., Karlsson E.K., Karolchik D., Kasprzyk A., Kawai J., Keibler E., Kells C., Kent W.J., Kirby A., Kolbe D.L., Korf I., Kucherlapati R.S., Kulbokas E.J., Kulp D., Landers T., Leger J.P., Leonard S., Letunic I., Levine R., Li J., Li M., Lloyd C., Lucas S., Ma B., Maglott D.R., Mardis E.R., Matthews L., Mauceli E., Mayer J.H., Mccarthy M., Mccombie W.R., Mclaren S., Mclay K., Mcpherson J.D., Meldrim J., Meredith B., Mesirov J.P., Miller W., Miner T.L., Mongin E., Montgomery K.T., Morgan M., Mott R., Mullikin J.C., Muzny D.M., Nash W.E., Nelson J.O., Nhan M.N., Nicol R., Ning Z., Nusbaum C., O'connor M.J., Okazaki Y., Oliver K., Overton-Larty E., Pachter L., Parra G., Pepin K.H., Peterson J., Pevzner P., Plumb R., Pohl C.S., Poliakov A., Ponce T.C., Ponting C.P., Potter S., Quail M., Reymond A., Roe B.A., Roskin K.M., Rubin E.M., Rust A.G., Santos R., Sapojnikov V., Schultz B., Schultz J., Schwartz M.S., Schwartz S., Scott C., Seaman S., Searle S., Sharpe T., Sheridan A., Shownkeen R., Sims S., Singer J.B., Slater G., Smit A., Smith D.R., Spencer B., Stabenau A., Stange-Thomann N., Sugnet C., Suyama M., Tesler G., Thompson J., Torrents D., Trevaskis E., Tromp J., Ucla C., Ureta-Vidal A., Vinson J.P., Von Niederhausern A.C., Wade C.M., Wall M., Weber R.J., Weiss R.B., Wendl M.C., West A.P., Wetterstrand K., Wheeler R., Whelan S., Wierzbowski J., Willey D., Williams S., Wilson R.K., Winter E., Worley K.C., Wyman D., Yang S., Yang S.P., Zdobnov E.M., Zody M.C., Lander E.S. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.
209. Weber B.H.F., Vogt G., Pruett R.C., Stohr H., Felbor U. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat. Genet. 1994, 8:352-356.
210. Weber B.H., Lin B., White K., Kohler K., Soboleva G., Herterich S., Seeliger M.W., Jaissle G.B., Grimm C., Reme C., Wenzel A., Asan E., Schrewe H. A mouse model for Sorsby fundus dystrophy. Invest. Ophthalmol. Vis. Sci. 2002, 43:2732-2740.
211. Weller R.O., Nicoll J.A. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol. Res. 2003, 25:611-616.
212. Wellington C.L. Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism. Clin. Genet. 2004, 66:1-16.
213. Weng J., Mata N.L., Azarian S.M., Tzekov R.T., Birch D.G., Travis G.H. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell 1999, 98:13-23.
214. Wenzel A., Grimm C., Samardzija M., Reme C.E. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog. Retin. Eye Res. 2005, 24:275-306.
215. Wiederanders B., Oelke B. Accumulation of inactive cathepsin D in old rats. Mech. Ageing Dev. 1984, 24:265-271.
216. Wikler K.W., Rakic P. Distribution of photoreceptor subtypes in the retina of diurnal and nocturnal primates. J. Neurosci. 1990, 10:3390-3401.
217. Wisniewski T., Ghiso J., Frangione B. Biology of A beta amyloid in Alzheimer's disease. Neurobiol. Dis. 1997, 4:313-328.
218. Wolfensberger T.J. Toxicology of the retinal pigment epithelium. The Retinal Pigment Epithelium 1998, Oxford University Press, pp. 621-647.
219. Won J., Smith R.S., Peachey N.S., Wu J., Hicks W.L., Naggert J.K., Nishina P.M. Membrane frizzled-related protein is necessary for the normal development and maintenance of photoreceptor outer segments. Vis. Neurosci. 2008, 25:563-574.
220. Wong T.Y., Loon S.C., Saw S.M. The epidemiology of age related eye diseases in Asia. Br. J. Ophthalmol. 2006, 90:506-511.
221. Magnitude and causes of visual impairment. Vol. Fact Sheet No. 282 2009, World Health Organization.
222. Xu Y.K., Nusse R. The frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases. Curr. Biol. 1998, 8:R405-R406.
223. Xu H., Chen M., Manivannan A., Lois N., Forrester J.V. Age-dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 2008, 7:58-68.
224. Xu H., Chen M., Forrester J.V. Para-inflammation in the ageing retina. Prog. Retin. Eye Res. 2009, 28:348-368.
225. Yoshida T., Ohno-Matsui K., Ichinose S., Sato T., Iwata N., Saido T.C., Hisatomi T., Mochizuki M., Morita I. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. J. Clin. Invest. 2005, 115:2793-2800.
226. Young R.W., Bok D. Participation of the retinal pigment epithelium in the rod outer segment renewal process. J. Cell Biol. 1969, 42:392-403.
227. Zack D.J., Dean M., Molday R.S., Nathans J., Redmond T.M., Stone E.M., Swaroop A., Valle D., Weber B.H. What can we learn about age-related macular degeneration from other retinal diseases?. Mol. Vis 1999, 5:30.
228. Zhang K., Kniazeva M., Han M., Li W., Yu Z., Yang Z., Li Y., Metzker M.L., Allikmets R., Zack D.J., Kakuk L.E., Lagali P.S., Wong P.W., Macdonald I.M., Sieving P.A., Figueroa D.J., Austin C.P., Gould R.J., Ayyagari R., Petrukhin K. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat. Genet. 2001, 27:89-93.
229. Zhang D., Lai M.C., Constable I.J., Rakoczy P.E. A model for a blinding eye disease of the aged. Biogerontology 2002, 3:61-66.
230. Zhang D., Brankov M., Makhija M.T., Robertson T., Helmerhorst E., Papadimitriou J.M., Rakoczy P.E. Correlation between inactive cathepsin D expression and retinal changes in mcd2/mcd2 transgenic mice. Invest. Ophthalmol. Vis. Sci. 2005, 46:3031-3038.
231. Zhang, J., Tuo, J., Cao, X., Shen, D., Chan, C.C., 2010. Synaptic pathology of photoreceptor terminals in Ccl2/Cx3cr1 deficient mice. ARVO Abstr. #4136.